These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16995346)

  • 1. Biomarker for IgM nephropathy variant and therapy.
    Futrakul N; Futrakul P
    Clin Nephrol; 2006 Sep; 66(3):218. PubMed ID: 16995346
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudohypercreatininaemia in two patients caused by monoclonal IgM interference with enzymatic assay of creatinine.
    Salter T; Marsh J; Sood B; Livingstone C; Gallagher H
    J Clin Pathol; 2015 Oct; 68(10):854-5. PubMed ID: 26060264
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity.
    Warnock DG; Remuzzi G; Brenner BM; Levin A; Wanner C
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):359. PubMed ID: 20019119
    [No Abstract]   [Full Text] [Related]  

  • 4. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.
    Hariri E; Mansour A; El Alam A; Daaboul Y; Korjian S; Aoun Bahous S
    Int Urol Nephrol; 2018 Jun; 50(6):1075-1083. PubMed ID: 29383580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On being better kidney doctors: understanding trajectories, probabilities, predictability, and people.
    Levin A; Djurdjev O
    Am J Kidney Dis; 2012 Apr; 59(4):475-7. PubMed ID: 22444489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progressive renal diseases: recent advances in diagnosis and treatments. Editorial: Disease concept and clinical research in kidney disease].
    Matsuo S
    Nihon Naika Gakkai Zasshi; 2013 May; 102(5):1067-9. PubMed ID: 23847969
    [No Abstract]   [Full Text] [Related]  

  • 7. IgM nephropathy presenting as full blown crescentic glomerulonephritis: first report in the literature.
    Kazi J; Mubarak M
    Nefrologia; 2014 May; 34(3):423-4. PubMed ID: 24849066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephropathy and pregnancy].
    Wauters JP
    Rev Med Suisse Romande; 1984 Aug; 104(8):583-7. PubMed ID: 6387849
    [No Abstract]   [Full Text] [Related]  

  • 9. Sickle cell nephropathy.
    Gargiulo R; Pandya M; Seba A; Haddad RY; Lerma EV
    Dis Mon; 2014 Oct; 60(10):494-9. PubMed ID: 25282510
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Setting the agenda. Acute kidney injury.
    Palevsky PM
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):933-4. PubMed ID: 18579670
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-alpha for IgM nephropathy?
    Liu S; Zhang D; Zhang Q; Liu W
    Clin Nephrol; 2014 Aug; 82(2):133-7. PubMed ID: 23380390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note.
    Tencer J; Torffvit O; Thysell H; Rippe B; Grubb A
    Kidney Int; 1998 Dec; 54(6):2098-105. PubMed ID: 9853275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of mesangial IgM nephropathy with decreased renal function.
    Yagame M; Tomino Y; Shibuya S; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):403-6. PubMed ID: 6400149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halting the progression of chronic nephropathy.
    Campbell RC; Ruggenenti P; Remuzzi G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S190-5. PubMed ID: 12466313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive nephropathy: pathophysiology, diagnosis, and collaborative management.
    Palmieri PA
    Nephrol Nurs J; 2002 Feb; 29(1):15-21, 96; quiz 22-3. PubMed ID: 11887486
    [No Abstract]   [Full Text] [Related]  

  • 17. IgM/IgA nephropathy in callitrichids: antigen studies.
    Brack M; Schroeder C; Fooke M; Schlumberger W
    Nephron; 1999; 82(3):221-31. PubMed ID: 10395994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new nephropathy: immunoglobulin light chain disease].
    Aparicio M; Potaux L; Bouchet JL; Bezian JH
    Presse Med; 1988 Dec; 17(44):2325-7. PubMed ID: 2974966
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring.
    Schena FP; Serino G; Sallustio F
    Nephrol Dial Transplant; 2014 Apr; 29(4):755-63. PubMed ID: 23787546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.